SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:145719494"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:145719494" > Stimulating the Res...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial

Arnardottir, H (author)
Karolinska Institutet
Pawelzik, SC (author)
Karolinska Institutet
Wistbacka, UO (author)
show more...
Artiach, G (author)
Hofmann, R (author)
Karolinska Institutet
Reinholdsson, I (author)
Braunschweig, F (author)
Karolinska Institutet
Tornvall, P (author)
Karolinska Institutet
Religa, D (author)
Karolinska Institutet
Back, M (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2021-01-11
2021
English.
In: Frontiers in physiology. - : Frontiers Media SA. - 1664-042X. ; 11, s. 624657-
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). SARS-CoV-2 triggers an immune response with local inflammation in the lung, which may extend to a systemic hyperinflammatory reaction. Excessive inflammation has been reported in severe cases with respiratory failure and cardiovascular complications. In addition to the release of cytokines, referred to as cytokine release syndrome or “cytokine storm,” increased pro-inflammatory lipid mediators derived from the omega-6 polyunsaturated fatty acid (PUFA) arachidonic acid may cause an “eicosanoid storm,” which contributes to the uncontrolled systemic inflammation. Specialized pro-resolving mediators, which are derived from omega-3 PUFA, limit inflammatory reactions by an active process called resolution of inflammation. Here, the rationale for omega-3 PUFA supplementation in COVID-19 patients is presented along with a brief overview of the study protocol for the trial “Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids - A single-blind, randomized, placebo-controlled feasibility study” (COVID-Omega-F). EudraCT: 2020-002293-28; clinicaltrials.gov: NCT04647604.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view